Charles Schwab Investment Management »

First Tracks Biotherapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 257k 20.12